PUBLIC NOTICE
Wednesday, March 26, 2003
the BATTAll!
As required by Section 54.0513, Paragraph (f) of the Texas
Education Code, the Board of Regents of The Texas A&M
University System will hold a public hearing to receive
input from students and the President regarding the
proposed increase in Designated Tuition for:
Congress debates cost of wa
By Suzanne Gamboa
THE ASSOCIATED PRESS
Texas A&M University
(includes Texas A&M University at Galveston)
FROM
TO
$44.00/SCH*
(2002-2003 academic year)
$46.00/SCH*
(2003-2004 academic year)
The hearing will be part of the Board of Regents' Meeting
scheduled to convene on March 27, 2003, at 10:00 a.m.,
in Room 292, Memorial Student Center, Joe Routt Boulevard,
Texas A&M University, College Station, Texas.
For additional information, please contact Vickie Burt
Spillers, Executive Secretary to the Board of Regents,
The Texas A&M University System, (979) 845-9600.
Issued this 21 s1 day of March 2003
Vickie Burt Spillers
Executive Secretary to the Board
*SCH-Semester Credit Hour
THINK
ABOUT
LAW
WASHINGTON — House
Majority Leader Tom DeLay said
Tuesday the cost of homeland
security will draw the most
debate as Congress tries to pro
vide the $74.7 billion President
Bush has requested to pay for the
war with Iraq and to strengthen
counterterrorism efforts at home.
“The basic debate is going to
be what is the federal responsibil
ity and what is the state and local
responsibility,” DeLay said.
Bush formally asked
Congress for the money for the
war Tuesday in a speech at the
Pentagon. About $62.6 billion of
the total is earmarked for the
Department of Defense, for six
months of operations in Iraq and
for stabilizing the country.
Another $4.2 billion is for
domestic security, including
money for state and local govern
ments. The total also contains
money for foreign aid and
humanitarian aid.
“The local governments and
the state governments and the
federal government have certain
responsibilities,” DeLay said.
“There are some in the House
and there are some in the Senate
that think the federal government
ought to be paying for everything
and that’s part of the reason they
want to beef up the spending on
homeland security.”
Congress is expected to hold
hearings this week on the
requested money. DeLay said he
would like to meet the president’s
request to have a bill to him by
April 11.
Democrats have criticized
Bush for not providing enough
money in his 2(X)4 budget for
homeland security and
Democratic candidates for
President have attacked Bush on
the issue.
DeLay said he expected
Democrats to ask for more home-
land security money.
“Democrats are always ask
ing for more money with little or
no credibility as to why they want
it,” DeLay said. “In many cases
it’s nothing but a partisan politi
cal ploy to constantly outbid the
president and use homeland secu
rity as a political issue.”
Rep. Kay Granger, who
served on the House Homeland
Security Committee, said she is
“reasonably comfortable” with
the homeland security money
Bush is requesting, although she
War costs
President Bush has asked
Congress for $747
for the war with Iraq
iL
$4.24 billion
for domestic secyn.
$7.85 billion
for humanitarian
reconstruction ani
foreign aid
$62.6 billion
for the Departed
Defense, incluto
troops in Iraq anc
other operations:!
terrorism
SOURCE: Associated Press
is awaiting hearings on thefc
ure to make a final determin nder Head Co;
“I don’t know what is em;
I know all our offices are»ec
requests on homeland se®
that is above (Bush's) ntti
A gg
Heari]
By
THE
There was a
exas A&M jun
r Chris Nelan I
ider his role oi
nd diving lean
Granger said. "The cities:
states are asking for
ears, Nelan had
“It was really
is,” Nash said. ‘
bought that ma;
natch, so we re
want to comb tfaroueh Ai ndgavehimtin
requests and make surewe’iei
picking up on things that aim
are funded or are putting ram danger to advei
in projects that are not proven'
DeLay said most of them®
for homeland security in
will go to the expansion oia
Coast Guard and for protect:;
ports in sensitive areas.
Nelan, who h;
ince he was 1
lercent of the I
lerson, he learm
hings in life do
I was mainst
NEWS IN BRIEF
FREE LAW SCHOOL FORUM
Meet with admissions officers from Texas,
Oklahoma and Louisiana Law Schools.
Gain invaluable admissions
information at the panel discussion.
Mentally ill inmate set to die
LIVINGSTON, Texas (AP) - A mentally ill Texas
death row inmate moved closer to execution when
the Texas Court of Criminal Appeals and a federal
district court refused to stop his punishment, sched
uled for Wednesday evening.
The Texas appeals court's rejection Tuesday of an
appeal from James Colburn, 43, returned his case to
the federal courts, where later in the day it was
turned down by a federal judge in Houston.
The former carpenter and bricklayer doesn'td
killing a woman at his home in Conroe hut I
lawyers contend the ninth-grade dropout i
criminal past includes arson and robbeiyt
tions should be spared because he suffers!
paranoid schizophrenia.
His lawyer indicated they may take the case to ft|
5th U.S. Circuit Court of Appeals in New Orleans
Wednesday, April 2 nd
6:00PM - 8:30PM
Texas A&M Campus
MSC Room 226
Space is limited!
Call 1-SOO-KAP-TEST or visit kaptest.com/law to register today.
Sponsored by
the leaders in
law preparation:
barbn
CoDtra.C6ptIV6 Inj0c1lion corYtcol you-tKiF'vk S&ourt jusT x a ye.3f~
medroxyprogesterone acetate injectable suspension
DEPO-PROVERA , ‘ Contraceptive Injection
(medroxyprogesterone acetate injectable suspension, USP)
This product is intended to prevent pregnancy. It does not protect against HIV
infection (AIDS) and other sexually transmitted diseases.
What is DEPO-PROVERA Contraceptive Injection?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an
intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To
continue your contraceptive protection, you must return for your next injection promptly at the
end of 3 months (I3 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a
chemical similar to (out not the same as) the natural hormone progesterone, which is produced
by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by
preventing your egg cells from ripening. If an egg is not released from the ovaries during your
menstruaf cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROVERA
also causes changes in the lining of your uterus that make it less likely for pregnancy to occur
How effective is DEPO-PFiOVERA Contraceptive Injection?
The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the
recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROVERA
Contraceptive Injection?"). To make sure you are not pregnant when you first get
~ ONLY during
DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during
the first 5 days of a normal menstrual period; ONLY witnin the first 5 days after childbirth if not
breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a
long-term injectable contraceptive when administered at 3-month (13-week) intervals.
DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable
methods of birth control available. This means that the average annual pregnancy rate is less than
• if you have had cancer of the breast
• if you have had a stroke
• if you have or have had blood clots (phlebitis) in your legs
• if you have problems with your liver or liver disease
• if you are allergic to PEPO-PROVERA (medroxyprogesterone acetate or any of its other
ingredients).
What other things should I consider before using DEPO-PROVERA
Contraceptive Injection?
You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is
important to tell your health-care provider if you have any of the following:
• a family history of breast cancer
• an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or
bleeding from your nipples
• kidney disease
• irregular or scanty menstrual periods
• high blood pressure
• migraine headaches
• asthma
• epilepsy (convulsions or seizures)
• diabetes or a family history of diabetes
• a history of depression
• if you are taking anv prescription or over-the-counter medications
This product is intended to prevent pregnancy. It does not protect against
transmission of HIV (AIDS) and other sexually transmitted diseases such as
chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis.
one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness of
DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other
contraceptive methods and give vou the information you need in order to decide which
contraceptive method is the right cn< '
: right choice for you.
The following table shows the percent of women who got pregnant while using different kinds of
contraceptive methods. It gives both the lowest expected rate of pregnancy (the ra t e expected
in women who use each method exactly as it should be used) ana the typical rate of pregnancy
(which includes women who became pregnant because they forgot to use their birth control or
because they did not follow the directions exactly).
Percent of Women Experiencing an Accidental Pregnancy
in the First Year of Continuous Use
Method
Lowest
Expected
Typical
DEPO-PROVERA
0.3
0.3
Implants (Norplant)
0.2*
0.2*
Female sterilization
0.2
0.4
Male sterilization
0.1
0.15
Oral contraceptive (pill)
3
Combined
0.1
Progestogen only
0.5
IUD
3
Progestasert
2.0
Copper T 380A
0.8
Condom (without spermicide)
2
12
Diaphragm (with spermicide)
6
18
Cervical cap
6
18
Withdrawal
4
18
Periodic abstinence
1-9
20
Spermicide alone
3
21
Vaginal Sponge
used before childbirth
6
18
used after childbirth
9
28
No method
85
85
What if I want to become pregnant after using DEPO-PROVERA Contraceptive
Injection?
Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last
injection for its effect to wear off. Based on the results from a large study done in the United States,
for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that
about half of those who become pregnant will do so in about 10 months after their last injection;
about two thirds of those who become pregnant will do so in about 12 months; about 83% of
those who become pregnant will do so in about 15 months; and about 93% of those who become
pregnant will do so in about 18 months after their last injection. The length of time you use
DEPO-PROVERA has no effect on how longit takesyou to become pregnant after you stop using it.
What are the risks of using DEPO-PROVERA Contraceptive Injection?
I .Irregular Menstrual bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for
contraception is a change in their normal menstrual cycle. During the first year of using
DEPO-PROVERA, you might have one or more of the following changes: irregular or
unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding
at all. Unusually heavy or continuous bleeding, however is not a usual effect of DEPO-PROVERA;
and if this happens, you should see your health-care provider right away. With continued use of
DEPO-PROVERA, bleeding usually decreases, and many women stop having periods completely.
In clinical studies of DEPO-PROVERA, 55% of the women studied reported no menstrual
bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual
bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA
causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the
regular monthly growth of the lining of your uterus does not occur and, therefore, the bleeding
that comes with your normal menstruation does not take place. When you stop using
DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle.
I. bone Mineral Changes
Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in
vour bones. This could increase your risk of developing bone fractures. The rate of bone mineral
loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the
normal rate of age-related bone mineral loss.
J. Cancer
Studies of women who have used different forms of contraception found that women who used
DEPO-PROVERA for contraception had no increased overall risk of developing cancer of the
breast, ovary, uterus, cervix, or liver However women under 35 years of age whose first exposure
to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased risk of
developing breast cancer similar to that seen with oral contraceptives. You should discuss this with
your healtn-
h-care provider
4.Unexpected Pregnancy
—O-PROVER
Source: Trussell et al. Obstet Gynecol. 1990:76:558-567.
*From Norplant* package insert.
Who should not use DEPO-PROVERA Contraceptive Injection?
~ jm
Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you have
any of the following conditions:
• if you think you might be pregnant
• if you have any vaginal bleeding without a known reason
Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental
pregnancy for women who get their shots regularly (every 3 months [I 3 weeks]) is very low.
while there have been reports of an increased risk of low birth weight and neonatal infant death
or other health problems in infants conceived close to the time of injection, such pregnancies are
uncommon. If you think you may have become pregnant while using DEPO-PRO'
contraception, see your health-care provider as soon as possible.
5Allergic Reactions
Some women using DEPO-PROVERA Contraceptive Injection have reported severe and
potentially life-threatening allergic reactions known as anaphylaxis and anaphylactoid reactions.
Symptoms include the sudden onset of hives or swelling and itching of the
difficulties, and a drop in blood pressure.
d.Othet Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots or
stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin
to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should
tell your health-care provider if you have any of the problems listed in the next section.
What symptoms may signal problems while using DEPO-PROVERA
Contraceptive Injectionr
Call your health-care provider immediately if any of these problems occur following an injection
of DEPO-PROVERA:
• sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot
in the lung)
• sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or
speech, weakness, or numbness in an arm or leg (indicating a possible stroke)
• severe pain or swelling in the calf (indicating a possible clot in the leg)
• unusually heavy vaginal bleeding
• severe pain or tenderness in the lower abdominal area
• persistent pain, pus, or bleeding at the injection site
What are the possible side effects of DEPO-PROVERA Contraceptive Injection?
I.Weight Gain
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of
the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds
during the first year of use. You may continue to gain weight after the first year Women in one
large study who used DEPO-PROVERA f
those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an
average total of I 3.8 pounds over those 4 years, or approximately 3.5 pounds per year. Women
average 1
who continued for 6 years gained an average total of 16.5 pounds
approximately 2.75 pounds per year
2.0ther Side tffects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal
cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal
discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet,
backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot
flashes, and joint pain. Other problems were reported by very few of the women in the clinical
trials^ but some of these could be serious. These include convulsions, jaundice, urinary tract
infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep 1
thrombosis, pulmonary embolus, breast cancer or cervical cancer If these or any other problems
occur during your use of DEPO-PROVERA, discuss them with your health-care provider
Should any precautions be followed during use of DEPO-PROVERA
Contraceptive injection?
1. Missed Periods
During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your
periods may stop completely. If you have been receiving your DEPO-PROVERA injections
regularly every 3 months (13 weeks), then you are probably not pregnant. However, if you think
that you may be pregnant, see your health-care provider
2. Laboratory Test Interactions
If you are scheduled for any laboratory tests, tell your health-care provider that you are using
DtPO-PROVERA for contraception. Certain blood te
DEPO-PROVERA.
S.Drug Interactions
Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the
effectiveness of DEPO-PROVERA if the two drugs are given during the same time.
4.Nursing Mothers
Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harmful
effects nave been found in these children. DEPO-PROVEFv^ does not prevent the breasts from
'reducing milk, so it can be used by nursing mothers. However to minimize the amount of
'EPO-PROVERA that is passed to the infant in the first weeks after birth, you should wait until
6 weeks after childbirth before you start using DEPO-PROVERA for contraception.
6 weeks alter childbirth before you start using UEru-rKCJvtKA tor contraception.
How often do I get my shot of DEPO-PROVERA Contraceptive Injection?
The recommended dose of DEPO-PROVERA is 150 mg every 3 months (13 weeks) given in a
single intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant
at the time of the first injection, it is essential that the injection be given ONLY during the first
5 days of a normal menstrual period. If used following the delivery of a child, the first injection of
DEPO-PROVERA MUST be given within 5 days after childbirth if you are not breast-feeding or
6 weeks after childbirth if you are exclusively breast-feeding. If you wait longer than 3 months
(13 weeks) between injections, or longer than 6 weeks after delivery, your health-care provider
should determine that you are not pregnant before giving you your injection of DEPO-PROVERA.
•VERA for Rx only
CB-7-S
he skin, breathing
Pharmacia & Upjohn Company
Kalamazoo, Ml 49001, USA
. Pharmacia
V&W & Upjohn